NRX Pharmaceuticals (NRXP) Total Debt (2018 - 2026)
NRX Pharmaceuticals (NRXP) posted Total Debt of $412,000 for Q2 2026, down 96.0% from $10.23 million a year earlier.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) Total Debt (2018 - 2026) Analysis & Trends
At the end of FY2024, NRX Pharmaceuticals' Total Debt came in at $1.57 million, down 82.9% from FY2023.
- Annual Total Debt shows a five-year compound annual growth rate of -4.3% (FY2019 to FY2024).
- In prior years, NRX Pharmaceuticals' Total Debt was $9.16 million in FY2023, $500,000 in FY2021 (-72.4%) and $1.81 million in FY2020 (-7.3%).
- The Q2 2026 figure stands as the lowest quarterly Total Debt since Q3 2019.
- On a year-over-year basis, Total Debt increased in two of the last four quarters, with growth averaging 244.8%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | NRX Pharmaceuticals | 126.02 Mn | 77.61 Mn | 426,000.00 | 412,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 412,000.00 |
| Sep 30, 2025 | 10.06 Mn |
| Jun 30, 2025 | 10.23 Mn |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 3.68 Mn |
| Jun 30, 2024 | 943,000.00 |
| Dec 31, 2023 | 9.16 Mn |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Mar 31, 2021 | 1.97 Mn |
| Dec 31, 2020 | 1.81 Mn |
| Sep 30, 2020 | 758,060.00 |
| Jun 30, 2020 | 685,476.00 |
| Mar 31, 2020 | 548,787.00 |
| Dec 31, 2019 | 1.95 Mn |
| Sep 30, 2019 | 327,198.00 |
| Jun 30, 2019 | 206,865.00 |
| Dec 31, 2018 | 690,000.00 |
API Access
NRX Pharmaceuticals Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();